Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Cécile Badier-Commander"'
Autor:
Michel Félétou, Alex Cordi, Jerome Paysant, Tony Verbeuren, Cécile Badier-Commander, Séverine Roger
Publikováno v:
Vascular Pharmacology. 53:281-287
The purpose of the present study was to determine whether an activator of soluble guanylyl cyclase (sGC), BAY 58-2667, inhibits platelet aggregation and to clarify its mechanism of action. Blood was collected from anesthetized WKY rats. The aggregati
Autor:
Michel Félétou, Séverine Roger, Alex Cordi, Cécile Badier-Commander, Tony Verbeuren, Jerome Paysant
Publikováno v:
British Journal of Pharmacology. 161:1044-1058
BACKGROUND AND PURPOSE The purpose of the present study was to determine whether a stimulator of soluble guanylyl cyclase, BAY 41-2272, inhibits platelet aggregation and to clarify its interaction with nitric oxide (NO). EXPERIMENTAL APPROACH Blood w
Autor:
Tony Verbeuren, Patricia Sansilvestri-Morel, Cécile Badier-Commander, Alain Rupin, Fabienne Bernhardt, Jean-Noël Fabiani, Olivier Chose
Publikováno v:
Journal of Cardiovascular Pharmacology. 51:131-139
Human saphenous veins (SV) are used for coronary bypass surgery despite the higher rate of graft failure observed as compared to arteries. A higher production of reactive oxygen species (ROS) in SV than in internal mammary artery (IMA) has been incri
Autor:
Tony Verbeuren, Pascale Gluais, Paul M. Vanhoutte, Cécile Badier-Commander, Jerome Paysant, Michel Félétou
Publikováno v:
American Journal of Physiology-Heart and Circulatory Physiology. 291:H2255-H2264
In mature spontaneously hypertensive rats (SHR) and Wistar-Kyoto rats (WKY), acetylcholine and the calcium ionophore A-23187 release endothelium-derived contracting factors (EDCFs), cyclooxygenase derivatives that activate thromboxane-endoperoxide (T
Autor:
Tony Verbeuren, Ziad Khabbaz, Paul Achouh, Cécile Badier-Commander, Catherine Chardigny, Jean-Noël Fabiani, Rachid Zegdi, Serge Simonet, Christine Vayssettes-Courchay
Publikováno v:
The Journal of Thoracic and Cardiovascular Surgery. 130(6):1573-1580
Objective Spasm remains a potential problem encountered during the use of arterial grafts in coronary artery bypass surgery. Heme oxygenase plays a role in the control of arterial vasoreactivity. Heme oxygenase exists in 2 constitutive isoforms (heme
Autor:
Ralf Köhler, Ludovic Waeckel, Heike Wulff, Patricia Sansilvestri-Morel, Christine Vayssettes-Courchay, Cécile Badier-Commander, Thibaut Damery, Serge Simonet, Michel Félétou
Publikováno v:
Waeckel, L, Badier-Commander, C, Damery, T, Köhler, R, Sansilvestri-Morel, P, Simonet, S, Vayssettes-Courchay, C, Wulff, H & Feletou, M 2015, ' Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm ', Pflügers Archiv-European Journal of Physiology, vol. 467, no. 9, pp. 1945-1963 . https://doi.org/10.1007/s00424-014-1644-6
Pflugers Archiv : European journal of physiology, vol 467, iss 9
Waeckel, L; Badier-Commander, C; Damery, T; Köhler, R; Sansilvestri-Morel, P; Simonet, S; et al.(2015). Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. Pflugers Archiv European Journal of Physiology, 467(9), 1945-1963. doi: 10.1007/s00424-014-1644-6. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0701s9v5
Pflugers Archiv : European journal of physiology, vol 467, iss 9
Waeckel, L; Badier-Commander, C; Damery, T; Köhler, R; Sansilvestri-Morel, P; Simonet, S; et al.(2015). Vascular dysfunctions in the isolated aorta of double-transgenic hypertensive mice developing aortic aneurysm. Pflugers Archiv European Journal of Physiology, 467(9), 1945-1963. doi: 10.1007/s00424-014-1644-6. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/0701s9v5
© Springer-Verlag Berlin Heidelberg 2014. Angiotensin-II and oxidative stress are involved in the genesis of aortic aneurysms, a phenomenon exacerbated by endothelial nitric oxide synthase (eNOS) deletion or uncoupling. The purpose of this work was
Autor:
Aliocha Scheuble, Jean-François Deux, P. Gabriel Steg, Elisabeth Brambilla, Marie-Paule Jacob, Mikael Mazighi, Cécile Badier-Commander, Laurent J. Feldman, Dominique Hénin, Edoardo De Benedetti
Publikováno v:
Scopus-Elsevier
Background —Intimal hyperplasia is the principal mechanism of in-stent restenosis. Matrix metalloproteinases (MMPs) play a key role in intimal growth after balloon angioplasty (BA). Little is known, however, about MMP expression after stent implant
Autor:
Tony Verbeuren, Willy Gosgnach, Nicolas Clavreul, Michel Félétou, Jean-Noël Fabiani, Christine Vayssettes-Courchay, Marie-Pierre Bourguignon, Cécile Badier-Commander, Alex Cordi, Ali Alshehri, Serge Simonet
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 386(3)
The purpose of the present work was to elucidate the mechanisms underlying the endothelium-dependent and endothelium-independent components of the vascular relaxation induced by a water-soluble and ruthenium-based carbon monoxide (CO)-releasing agent
Autor:
Harry A.J. Struijker-Boudier, E. Masih-Khan, S. Kai, Charles Parnot, Valérie Marque, Richard E. Gilbert, Paul M. Vanhoutte, Patrick Kern, Domenico Ribatti, Darren J. Kelly, Amauri Cruz, David A.S.G. Mary, Alessandra Battaglia, Li-Hong Yeh, Jennifer L. Wilkinson-Berka, Cécile Badier-Commander, Nicola Surico, Tony Verbeuren, Marian T. Nakada, Guy Lagaud, Jean-Noël Fabiani, Subroto Chatterjee, Adam M. Kinsey, Giovanni Vacca, Helma van Essen, C. van Breemen, Pierre Corvol, Alain Rupin, Elena Grossini, Isabelle Lartaud-Idjouadiene, Patricia Sansilvestri-Morel, Jean-Marie Gasc, Michelle P. Bendeck, Jeffrey Atkinson, Claudio Molinari, G.P. Dubé, B. Rita Alevriadou
Publikováno v:
Journal of Vascular Research. 37:68-70
Autor:
Tony Verbeuren, Cécile Badier-Commander, D. Behr-Roussel, Serge Simonet, Sophie Coumailleau, Alain Rupin
Publikováno v:
European journal of pharmacology. 492(2-3)
The inducible form of nitric oxide synthase (iNOS) is present in advanced atherosclerotic lesions. The aim of the present paper was to compare the functionality of iNOS in rabbits fed a 0.3% cholesterol-diet for 24 weeks (Baseline), and 36 weeks, wit